Welcome to LookChem.com Sign In|Join Free

CAS

  • or

183741-98-2

Post Buying Request

183741-98-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

183741-98-2 Usage

General Description

Pyrido[3,4-d]pyrimidin-4(1H)-one, 6-methoxy- is a chemical compound with the molecular formula C10H8N2O2. It belongs to the class of pyrido[3,4-d]pyrimidine derivatives and is characterized by a pyrimidine ring fused to a pyridine ring with a methoxy group attached at the 6th position. Pyrido[3,4-d]pyrimidin-4(1H)-one, 6-methoxy- has potential pharmacological properties, such as anticancer and antiviral activities, and may be used in the development of novel drugs. It is also a valuable compound for research purposes in the fields of medicinal chemistry and pharmacology.

Check Digit Verification of cas no

The CAS Registry Mumber 183741-98-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,7,4 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 183741-98:
(8*1)+(7*8)+(6*3)+(5*7)+(4*4)+(3*1)+(2*9)+(1*8)=162
162 % 10 = 2
So 183741-98-2 is a valid CAS Registry Number.

183741-98-2Downstream Products

183741-98-2Relevant articles and documents

HETEROCYCLIC INHIBITORS OF TYROSINE KINASE

-

, (2020/11/03)

The present disclosure relates to heterocyclic compounds and methods which may be useful as inhibitors of HER2 or EGFR for the treatment or prevention of disease, including cancer.

IDENTIFICATION AND USE OF ERK5 INHIBITORS

-

Page/Page column 51; 103-104, (2019/10/01)

The present invention covers heterocyclic compounds of general formula (I) in which T, U, Y, Z, R1 and R3 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of cancer disorders, as a sole agent or in combination with other active ingredients.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 183741-98-2